Lanraplenib (LANRA)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Lanraplenib (LANRA), covering 2024-08-07 to 2024-08-07. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate Lanraplenib (LANRA) in Combination With Gilteritinib in Participants With FLT3-mutated Relapsed or Refractory Acute Myeloid Leukemia (AML) [Phase 1, Phase 2]